Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas. Ahvenainen T, Kaukomaa J, Kampjarvi K, Uimari O, et al. Am J Surg Pathol 2021 Oct 25. pii: 00000478-900000000-97109.

Read + Share

Amedeo Smart

Independent Medical Education

Ahvenainen T, Kaukomaa J, Kampjarvi K, Uimari O, et al. Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas. Am J Surg Pathol 2021 Oct 25. pii: 00000478-900000000-97109.
PMID: 34678832